Cyclooxygenase-2 expression, Ki-67 labeling index, and perifocal neovascularization in endometriotic lesions

Annals of Diagnostic Pathology

Volumn 13, Issue 6, 2009, Pages 373-377

  Horn, Lars Christian ^a   Hentschel, Bettina ^a   Meinel, Alexandra ^a   Alexander, Henry ^a   Leo, Cornelia ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Angiogenesis; COX 2; Endometriosis; Ovary; Proliferation

Indexed keywords

CYCLOOXYGENASE 2; KI 67 ANTIGEN;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOMETRIOSIS; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGICAL ANATOMY; PRIORITY JOURNAL;

CELL PROLIFERATION; CHI-SQUARE DISTRIBUTION; CYCLOOXYGENASE 2; ENDOMETRIOSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN DISEASES; PERITONEAL DISEASES; STATISTICS, NONPARAMETRIC; UTERINE DISEASES;

EID: 71549116066     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2009.08.001     Document Type: Article

References (30)

1. Amir M., and Agarwal H.K. Role of COX-2 selective inhibitors for prevention and treatment of cancer. Pharmazie 60 (2005) 563-570
2. Lin M.T., Lee R.C., Yang P.C., Ho F.M., and Kuo M.L. Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem 276 (2001) 48997-49002
3. Gately S., and Li W.W. Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy. Semin Oncol 31 (2004) 2-11
4. Singh B., Berry J.A., Shoher A., Ramakrishnan V., and Lucci A. COX-2 overexpression increases motility and invasion of breast cancer cells. Int J Oncol 26 (2005) 1393-1399
5. Chishima F., Hayakawa S., Sugita K., Kinukawa N., Aleemuzzaman S., Nemoto N., et al. Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients. Am J Reprod Immunol 48 (2002) 50-56
6. Ota H., Igarashi S., Sasaki M., and Tanaka T. Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis. Hum Reprod 16 (2001) 561-566
7. Banu S.K., Lee J., Speights Jr. V.O., Starzinski-Powitz A., and Arosh J.A. Cyclooxygenase-2 regulates survival, migration, and invasion of human endometriotic cells through multiple mechanisms. Endocrinology 149 (2008) 1180-1189
8. Laschke M.W., Elitzsch A., Scheuer C., Vollmar B., and Menger M.D. Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis. Fertil Steril 87 (2007) 163-171
9. Dogan E., Saygili U., Posaci C., Tuna B., Caliskan S., Altunyurt S., et al. Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib. Fertil Steril 82 Suppl 3 (2004) 1115-1120
10. Ozawa Y., Murakami T., Tamura M., Terada Y., Yaegashi N., and Okamura K. A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis xenografts via antiangiogenic activity in severe combined immunodeficiency mice. Fertil Steril 86 Suppl (2006) 1146-1151
11. Fagotti A., Ferrandina G., Fanfani F., Legge F., Lauriola L., Gessi M., et al. Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinico-pathological parameters. Hum Reprod 19 (2004) 393-397
12. Maia Jr. H., Casoy J., Correia T., Freitas L., Pimentel K., Athayde C., et al. Effect of the menstrual cycle and oral contraceptives on aromatase and cyclooxygenase-2 expression in adenomyosis. Gynecol Endocrinol 22 (2006) 547-551
13. Buchweitz O., Staebler A., Wülfing P., Hauzman E., Greb R., and Kiesel L. COX-2 overexpression in peritoneal lesions is correlated with nonmenstrual chronic pelvic pain. Eur J Obstet Gynecol Reprod Biol 124 (2006) 216-221
14. Denkert C., Köbel M., Pest S., Koch I., Berger S., Schwabe M., et al. Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma. Am J Pathol 160 (2002) 893-903
15. Chou Y.C., Chen Y.J., Lai C.R., Wang P.H., Hsin-Chan, and Yuan C.C. Cyclooxygenase-2 expression is higher in ovarian cancer tissue adjacent to endometriosis than in ovarian cancer without comorbid endometriosis. Eur J Obstet Gynecol Reprod Biol 124 (2006) 101-105
16. Leo C., Faber S., Hentschel B., Höckel M., and Horn L.C. The status of cyclooxygenase-2 expression in ductal carcinoma in situ lesions and invasive breast cancer correlates to cyclooxygenase-2 expression in normal breast tissue. Ann Diagn Pathol 10 (2006) 327-332
17. Horn L.C., Hentschel B., Bilek K., Richter C.E., Einenkel J., and Leo C. Mixed small cell carcinomas of the uterine cervix: prognostic impact of focal neuroendocrine differentiation but not of Ki-67 labeling index. Ann Diagn Pathol 10 (2006) 140-143
18. Weidner N., Semple J.P., Welch W.R., and Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324 (1991) 1-8
19. Palmer J., Sant Cassia L.J., Irwin C.J., Morris A.G., and Rollason T.P. Prognostic value of measurements of angiogenesis in serous carcinoma of the ovary. Int J Gynecol Pathol 26 (2007) 395-403
20. Ceyhan S.T., Onguru O., Baser I., and Gunhan O. Expression of cyclooxygenase-2 and vascular endothelial growth factor in ovarian endometriotic cysts and their relationship with angiogenesis. Feril Steril 90 (2008) 988-993
21. Wu Y., and Guo S.W. Suppression of IL-1beta-induced COX-2 expression by trichostatin A (TSA) in human endometrial stromal cells. Eur J Obstet Gynecol Reprod Biol 135 (2007) 88-93
22. Matsuzaki S., Canis M., Darcha C., Dallel R., Okamura K., and Mage G. Cyclooxygenase-2 selective inhibitor prevents implantation of eutopic endometrium to ectopic sites in rats. Fertil Steril 82 (2004) 1609-1615
23. Esfandiari N., Ai J., Nazemian Z., Javed M.H., Gotlieb L., and Casper R.F. Expression of glycodelin and cyclooxygenase-2 in human endometrial tissue following three-dimensional culture. Am J Reprod Immunol 57 (2007) 49-54
24. Cobellis L., Razzi S., De Simone S., Sartini A., Fava A., Danero S., et al. The treatment with a COX-2 specific inhibitor is effective in the management of pain related to endometriosis. Eur J Obstet Gynecol Reprod Biol 116 (2004) 100-102
25. Ebert A.D., Bartley J., and David M. Aromatase inhibitors and cyclooxygenase-2 (COX-2) inhibitors in endometriosis: new questions-old answers?. Eur J Obstet Gynecol Reprod Biol 122 (2005) 144-150
26. Stern R.C., Dash R., Bentley R.C., Snyder M.J., Haney A.F., and Robboy S.J. Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types. Int J Gynecol Pathol 20 (2001) 133-139
27. Brinton L.A., Gridley G., Persson I., Baron J., and Bergqvist A. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 176 (1997) 572-579
28. Jarboe E.A., Folkins A.K., Drapkin R., Ince T.A., Agoston E.S., and Crum C.P. Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective. Histopathology 53 (2008) 127-138
29. Li S., Miner K., Fannin R., Carl Barrett J., and Davis B.J. Cyclooxygenase-1 and 2 in normal and malignant human ovarian epithelium. Gynecol Oncol 92 (2004) 622-627
30. Yang W.L., Roland I.H., Godwin A.K., and Xu X.X. Loss of TNF-alpha-regulated COX-2 expression in ovarian cancer cells. Oncogene 24 (2005) 7991-8002